Roche received a FDA CLIA waiver for its rapid point-of-care test to detect and differentiate influenza A virus and influenza B virus, using its cobas Liat PCR System.
FDA Approvals …read more
Roche received a FDA CLIA waiver for its rapid point-of-care test to detect and differentiate influenza A virus and influenza B virus, using its cobas Liat PCR System.
FDA Approvals …read more
Comments are closed.
Nice posts! 🙂
___
Sanny
http://afcmarseille.com